Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?

No clinical characteristics, particularly not sputum characteristics, can guide antibiotic prescription in patients with mild to severe COPD exacerbations https://bit.ly/3e1JV8o

Detalles Bibliográficos
Autores principales: van Velzen, Patricia, ter Riet, Gerben, Brinkman, Paul, Sterk, Peter J., Prins, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248336/
https://www.ncbi.nlm.nih.gov/pubmed/32494571
http://dx.doi.org/10.1183/23120541.00099-2020
_version_ 1783538349782335488
author van Velzen, Patricia
ter Riet, Gerben
Brinkman, Paul
Sterk, Peter J.
Prins, Jan M.
author_facet van Velzen, Patricia
ter Riet, Gerben
Brinkman, Paul
Sterk, Peter J.
Prins, Jan M.
author_sort van Velzen, Patricia
collection PubMed
description No clinical characteristics, particularly not sputum characteristics, can guide antibiotic prescription in patients with mild to severe COPD exacerbations https://bit.ly/3e1JV8o
format Online
Article
Text
id pubmed-7248336
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-72483362020-06-02 Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits? van Velzen, Patricia ter Riet, Gerben Brinkman, Paul Sterk, Peter J. Prins, Jan M. ERJ Open Res Original Research Letters No clinical characteristics, particularly not sputum characteristics, can guide antibiotic prescription in patients with mild to severe COPD exacerbations https://bit.ly/3e1JV8o European Respiratory Society 2020-05-26 /pmc/articles/PMC7248336/ /pubmed/32494571 http://dx.doi.org/10.1183/23120541.00099-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
van Velzen, Patricia
ter Riet, Gerben
Brinkman, Paul
Sterk, Peter J.
Prins, Jan M.
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title_full Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title_fullStr Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title_full_unstemmed Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title_short Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
title_sort doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248336/
https://www.ncbi.nlm.nih.gov/pubmed/32494571
http://dx.doi.org/10.1183/23120541.00099-2020
work_keys_str_mv AT vanvelzenpatricia doxycyclineforexacerbationsofchronicobstructivepulmonarydiseaseinoutpatientswhobenefits
AT terrietgerben doxycyclineforexacerbationsofchronicobstructivepulmonarydiseaseinoutpatientswhobenefits
AT brinkmanpaul doxycyclineforexacerbationsofchronicobstructivepulmonarydiseaseinoutpatientswhobenefits
AT sterkpeterj doxycyclineforexacerbationsofchronicobstructivepulmonarydiseaseinoutpatientswhobenefits
AT prinsjanm doxycyclineforexacerbationsofchronicobstructivepulmonarydiseaseinoutpatientswhobenefits

Ejemplares similares